Sequencing therapies in Hodgkin lymphoma

Lancet Haematol. 2021 Aug;8(8):e537-e539. doi: 10.1016/S2352-3026(21)00200-3.
No abstract available

MeSH terms

  • Antineoplastic Agents / therapeutic use
  • Antineoplastic Agents, Immunological / therapeutic use
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Bleomycin / therapeutic use
  • Brentuximab Vedotin / therapeutic use
  • Carboplatin / therapeutic use
  • Dacarbazine / therapeutic use
  • Disease Management
  • Doxorubicin / therapeutic use
  • Etoposide / therapeutic use
  • Hematopoietic Stem Cell Transplantation
  • Hodgkin Disease / therapy*
  • Humans
  • Ifosfamide / therapeutic use
  • Vinblastine / therapeutic use

Substances

  • Antineoplastic Agents
  • Antineoplastic Agents, Immunological
  • Bleomycin
  • Vinblastine
  • Etoposide
  • Dacarbazine
  • Brentuximab Vedotin
  • Doxorubicin
  • Carboplatin
  • Ifosfamide

Supplementary concepts

  • ABVD protocol